```html

Viral Bronchiolitis – Comprehensive Medical Guide

Overview

Bronchiolitis is an acute inflammation of the bronchioles—the smallest airways in the lungs. In most cases it is caused by a viral infection, most commonly respiratory syncytial virus (RSV). The condition typically presents with wheezing, coughing, and difficulty breathing.

Bronchiolitis is primarily a disease of infants and young children, although older children and adults with compromised immune systems can be affected.

• Age group most affected: 0‑24 months, with a peak incidence at 2‑6 months.
• Incidence: In the United States, bronchiolitis accounts for ~3 million outpatient visits and ~100,000 hospitalizations each year. RSV alone infects ~2 million children <5 years annually worldwide, and up to 30 % develop bronchiolitis. CDC, 2024
• Seasonality: Peaks during the fall–winter months in temperate climates; in tropical regions, it follows the rainy season.

Symptoms

Symptoms evolve over several days and may range from mild to severe. The classic progression is:

• Day 1‑2 (upper‑respiratory phase): Runny nose, low‑grade fever (≤38 °C), and mild cough.
• Day 3‑5 (lower‑respiratory phase): Rapid breathing (tachypnea), wheezing, crackles, and increased effort to breathe.
• Day 5‑7 (recovery or worsening): Symptoms either improve or, in severe cases, lead to hypoxia, apnea, or secondary infection.

Complete Symptom List

• Runny or stuffy nose (rhinorrhea)
• Low‑grade fever (often <38 °C, but may be absent)
• Dry, hacking cough
• Wheezing (high‑pitched whistling sound)
• Crackles (rales) heard on lung exam
• Rapid breathing (>60 breaths/min in infants, >40 in toddlers)
• Chest retractions (skin pulling in between ribs or under the breastbone)
• Difficulty feeding or poor weight gain (due to breathlessness while sucking)
• Irritability or lethargy
• Decreased urine output (sign of dehydration)
• Apnea (brief pauses in breathing) – more common in infants <2 months

Causes and Risk Factors

Bronchiolitis is almost always viral. The most common pathogens are:

• Respiratory Syncytial Virus (RSV): Responsible for 60‑80 % of cases.
• Human rhinovirus (HRV)
• Human metapneumovirus (hMPV)
• Parainfluenza viruses (Types 1‑3)
• Influenza A/B (less common)
• Coronavirus (including seasonal strains)

Risk Factors that Increase Severity

• Prematurity (<37 weeks gestation) or low birth weight
• Chronic lung disease of prematurity (e.g., bronchopulmonary dysplasia)
• Congenital heart disease (especially with left‑to‑right shunts)
• Immunodeficiency (primary or secondary)
• Exposure to tobacco smoke, indoor air pollutants, or crowded daycare settings
• Sibling or household contact with recent respiratory infection
• Underlying neurological conditions that impair airway clearance

These factors do not cause bronchiolitis, but they predispose to more severe disease and hospitalization.

Diagnosis

Bronchiolitis is primarily a clinical diagnosis based on history and physical examination. Laboratory and imaging studies are reserved for atypical presentations, severe disease, or to rule out complications.

Key Diagnostic Steps

1. History: Recent upper‑respiratory symptoms, exposure to sick contacts, seasonality, and risk‑factor assessment.
2. Physical Exam: Observation of tachypnea, use of accessory muscles, auscultation for wheeze/crackles, and assessment of hydration status.
3. Pulse Oximetry: Oxygen saturation <94 % on room air is a red flag indicating need for supplemental O₂.

Optional Tests

• Nasopharyngeal swab PCR: Detects RSV or other viruses; useful for infection control but does not change acute management.
• Chest X‑ray: Typically not required; may show hyperinflation or peribronchial thickening. Ordered if bacterial pneumonia is suspected.
• Complete blood count (CBC): May show mild leukocytosis; rarely needed.
• Blood gases: In severe cases to evaluate CO₂ retention.

Reference: American Academy of Pediatrics (AAP) Clinical Practice Guideline, 2023 AAP, 2023.

Treatment Options

There is no cure for the viral infection itself; treatment focuses on supportive care and preventing complications.

Supportive Care (mainstay)

• Hydration: Frequent feeding for infants; consider nasogastric or IV fluids if oral intake is insufficient.
• Oxygen therapy: Supplemental O₂ to maintain SpO₂ ≥ 94 % (≥ 90 % in chronic lung disease). Delivered via nasal cannula or hood.
• Airway clearance: Gentle suctioning of nasal secretions; chest physiotherapy is not routinely recommended.
• Fever control: Acetaminophen or ibuprofen (age‑appropriate) for comfort.

Medications

• Bronchodilators (e.g., albuterol): Not routinely recommended; may be trialed in children with wheeze and underlying reactive airway disease.
• Ribavirin (inhaled): Reserved for severely ill immunocompromised patients; high cost and limited evidence.
• Palivizumab (monoclonal antibody): Prophylaxis, not treatment—given monthly during RSV season to high‑risk infants (premature, congenital heart disease, chronic lung disease). CDC, 2024
• Antibiotics: Not indicated unless there is clear bacterial co‑infection (e.g., otitis media, pneumonia).

Procedures for Severe Cases

• High‑flow nasal cannula (HFNC) or continuous positive airway pressure (CPAP) for respiratory distress.
• Intubation and mechanical ventilation only in cases of respiratory failure.
• In rare instances, extracorporeal membrane oxygenation (ECMO) for refractory hypoxemia.

Home‑care Recommendations

• Continue routine immunizations; influenza vaccine is especially important for caregivers.
• Monitor temperature and feeding; keep a fluid log.
• Elevate the infant’s head slightly (prop with a towel) to aid breathing.

Living with Viral Bronchiolitis

Most children recover completely within 1‑2 weeks, but the illness can be stressful for families. Practical tips:

Daily Management

• Frequent, small feeds: Offer breast milk or formula every 2‑3 hours; use a syringe or cup if the infant tires quickly.
• Humidified air: A cool‑mist humidifier can soothe irritated airways, but keep it clean to avoid mold.
• Nasal suction: Use a bulb syringe or nasal aspirator before feeds and after crying.
• Positioning: Holding the infant upright during and after feeds reduces aspiration risk.
• Temperature checks: Record twice daily and call a provider if fever >39 °C (102.2 °F) persists >48 h.
• Hydration monitoring: Count wet diapers (≥ 6 per day is reassuring).

Emotional Support

• Ask for help from family or friends for meals and household chores.
• Join parent support groups (online forums or local hospital groups) to share experiences.
• Keep a symptom diary—this helps clinicians see trends and decide on escalation.

Prevention

Because bronchiolitis is viral, infection‑control measures are key.

Primary Prevention

• Hand hygiene: Wash hands with soap for ≥20 seconds before touching the infant.
• Limit exposure: Avoid crowded places and sick contacts during peak RSV season.
• Breastfeeding: Provides maternal antibodies that lower risk of severe RSV infection.
• Vaccination of caregivers: Annual influenza vaccine; COVID‑19 vaccine up to date.
• Environmental control: Keep indoor air smoke‑free; use air purifiers if indoor allergens are high.

Prophylaxis for High‑Risk Infants

• Palivizumab (Synagis): 15 mg/kg monthly intramuscular injection during RSV season for eligible infants.
• Check eligibility with your pediatrician—criteria include gestational age <29 weeks, chronic lung disease, or significant congenital heart disease.

Complications

While many children recover without sequelae, complications can arise, especially in high‑risk groups.

• Respiratory failure: Requires ICU admission, mechanical ventilation.
• Apnea: Particularly in infants <2 months; may need monitoring.
• Bacterial superinfection: Otitis media, sinusitis, or pneumonia.
• Dehydration: From poor intake; may need IV fluids.
• Long‑term wheezing or asthma: Children with severe bronchiolitis have a 2‑3 × higher risk of developing recurrent wheeze or asthma later in childhood. Cleveland Clinic, 2023

When to Seek Emergency Care

---

**Sources**: Mayo Clinic, CDC, NIH, WHO, American Academy of Pediatrics, Cleveland Clinic, peer‑reviewed journals (e.g., Journal of Pediatrics 2022; Lancet Respiratory Medicine 2023).

```